ADAPTING TREATMENT IN METASTATIC HR+/HER2− BREAST CANCER, AFTER CHEMOTHERAPY REFUSAL: A CASE REPORT
This study case represent breast cancer with positive hormone receptors and HER2-negative status shows the most usual subtype in metastatic breast carcinoma. Clinical management is frequently derived from endocrine therapy together with certain agents. The therapeutic option affected not only by the biological characte...